Health Indicator Report of Cancer Incidence - Mesothelioma
Mesothelioma is a relatively rare form of cancer that is primarily associated with long term exposure to asbestos. The majority of cases occur in males with a work history of prolonged exposure to asbestos. Mesothelioma can be difficult to diagnose, and most cases are not discovered until the cancer has spread throughout the body, making treatment difficult and the survival relatively low. Mesothelioma is relatively rare in the United States, and New Mexico averaged 17 new cases each year between 2010 and 2015. Because asbestos exposure is the predominant risk factor for developing mesothelioma, the vast majority of these cases are preventable by limiting exposure to asbestos.
NotesData have been age-adjusted to the U.S. 2000 standard population.
- Numerator: The New Mexico Tumor Registry, University of New Mexico Health Sciences Center, http://hsc.unm.edu/som/nmtr/.
- New Mexico Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program, http://gps.unm.edu/.
DefinitionMesothelioma incidence refers to the number of persons newly diagnosed with mesothelioma during a specified time period. Measures include 1) the number of newly diagnosed mesothelioma cases; and 2) age-adjusted mesothelioma incidence rates (adjusted to the 2000 US standard population). All rates are expressed per 100,000 persons. Measures are provided by sex and race/ethnicity.
NumeratorThe number of mesothelioma cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for mesothelioma (SEER Recode B 36010); ICD-O-3 codes: histologies 9050-9055; Malignant cases: ICD behavior code 3.
DenominatorThe estimated population of New Mexico residents within a specified time period.
Other ObjectivesCDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)
Page Content Updated On 01/09/2019, Published on 05/16/2019